Sign in Subscribe

Topic

March 2025

A collection of 100 issues

Conifer Holdings, Inc.

Conifer Holdings, Inc. is an insurance holding company based in Michigan, traditionally involved in a diverse portfolio of insurance operations including commercial lines, personal lines, and agency business. Recently, however, the company has undergone a dramatic strategic and operational transf...

Muzinich BDC, Inc.

Investors attracted to income-generating securities and comfortable with the complexities of the private debt market might find Muzinich BDC, Inc. to be an interesting proposition. The company’s model of targeting middle-market firms through various forms of debt is designed to take advantage of ...

PermRock Royalty Trust

Investors looking for income-generating opportunities in the energy sector sometimes turn to royalty trusts. In this post, we dive deep into the 10-K filing of PermRock Royalty Trust to assess its business model, financial performance, risks, and overall investment potential....

HEALTHY CHOICE WELLNESS CORP.

Healthy Choice Wellness Corp. (HCWC) has recently emerged as an independent, publicly traded entity following its spin-off from Healthier Choices Management Corp. (HCMC). This extensive 10-K filing provides a wealth of information on the company’s business segments, financial performance, risks, ...

CYBERLOQ TECHNOLOGIES, INC.

CyberloQ Technologies, Inc. is a development-stage technology company that is trying to carve out a niche in the competitive and highly challenging markets of fraud prevention and credit management. The company’s 10-K filing reveals an organization with innovative proprietary technologies but sig...

HG Holdings, Inc.

HG Holdings, Inc. is a company that has undergone a significant transformation over the past few years. Originally incorporated as a furniture company, it shifted focus in 2018 after an asset sale to reinvent itself as a provider of title insurance and related services, with a strategic emphasis ...

DURECT CORP

DURECT Corporation is a company that many biotech investors keep a close eye on due to its innovative approach in the biopharmaceutical sector. By harnessing its proprietary Epigenetic Regulator Program, the company aims to develop novel, potentially life-saving therapies. At the heart of its eff...

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company with an ambitious mission: to pioneer a disease-modifying treatment approach for Alzheimer’s disease (AD). As detailed in its latest 10-K filing, the company is advancing sabirnetug, a novel antibody that selectively targe...

ALLURION TECHNOLOGIES, INC.

Allurion Technologies, Inc. has positioned itself in the weight loss arena with one striking mission: to end obesity through a best-in-class, non-invasive weight loss platform. Their innovative product suite combines the world’s first swallowable, procedureless intragastric balloon – known as the...

Vincerx Pharma, Inc.

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company operating primarily through a license with Bayer. This comprehensive 10-K filing reveals a company with promising science, a robust pipeline, and a clear focus on innovative drug development, but it also highlights significant ris...